Ultragenyx PharmaceuticalRARE
那斯達克 · USD
28.44
+1.12
(+4.10%)
收盤 08/02 03:59 (UTC+8)
盤後
28.34
28.34
(-0.37%)
08/02 03:59 (UTC+8)
Ultragenyx PharmaceuticalRARE
28.44
+1.12
(+4.10%)
財務數據
損益表
- 1.03
- 1.00
- 1.08
- 0.98
- 1.27
- 1.09
- 1.47
- 1.39
- 1.65
- 1.39
- 13.94
- -2.76
- 7.77
- -9.47
- 29.92
- -14.57
- 35.09
- -5.12
- 18.20
- -15.52
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 139,292 | 164,877 | 139,494 | 147,026 | 108,833 | 127,392 | 98,052 | 108,309 | 100,496 | 103,348 |
營業成本 | 28,662 | 16,894 | 21,021 | 21,280 | 17,533 | 12,051 | 10,987 | 9,914 | 12,257 | 5,319 |
營業毛利 | 110,630 | 147,983 | 118,473 | 125,746 | 91,300 | 115,341 | 87,065 | 98,395 | 88,239 | 98,029 |
營業費用 | 253,569 | 270,261 | 250,460 | 242,107 | - | 237,390 | 232,162 | 246,352 | 242,344 | 243,657 |
研發費用 | 165,772 | 187,766 | 170,109 | 161,503 | 178,487 | 160,557 | 157,245 | 164,949 | 165,698 | 170,808 |
推銷及管理費用 | 87,797 | 82,495 | 80,351 | 80,604 | 78,160 | 76,833 | 74,917 | 81,403 | 76,646 | 72,849 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -142,939 | -122,278 | -131,987 | -116,361 | -165,347 | -122,049 | -145,097 | -147,957 | -154,105 | -145,628 |
其他收入及費用 | 7,668 | 5,944 | 13,808 | 5,572 | 7,219 | 10,596 | 5,182 | 3,975 | 6,598 | 6,378 |
利息費用 | 14,342 | 15,522 | 15,712 | 15,960 | 15,847 | 17,328 | 17,665 | 15,375 | 15,636 | 15,874 |
稅前純益 | -149,770 | -133,404 | -133,213 | -130,740 | -170,229 | -126,892 | -158,999 | -159,096 | -163,477 | -153,284 |
所得稅 | 1,310 | -19 | 303 | 858 | 455 | -3,702 | 650 | 732 | 495 | -1,451 |
稅後純益 | -151,080 | -133,385 | -133,516 | -131,598 | -170,684 | -123,190 | -159,649 | -159,828 | -163,972 | -151,833 |
基本每股稅後盈餘(元) | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 | -2.23 | -2.25 | -2.33 | -2.16 |
稀釋每股稅後盈餘(元) | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 | -2.23 | -2.25 | -2.33 | -2.16 |
基本平均股數(千股) | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 | 71664.00 | 70897.00 | 70368.00 | 70152.00 |
稀釋平均股數(千股) | 96288.00 | 95681.00 | 95493.00 | 86580.00 | 84286.00 | 81118.00 | 71664.00 | 70897.00 | 70368.00 | 70152.00 |
還原基本每股稅後盈餘(元) | -1.57 | -1.39 | -1.40 | -1.52 | -2.03 | -1.52 | -2.23 | -2.25 | -2.33 | -2.16 |
還原稀釋每股稅後盈餘(元) | -1.57 | -1.38 | -1.37 | -1.51 | -2.03 | -1.44 | -2.23 | -2.25 | -2.33 | -2.16 |
還原基本平均股數(千股) | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 | 71,664 | 70,897 | 70,368 | 70,152 |
還原稀釋平均股數(千股) | 96,288 | 95,681 | 95,493 | 86,580 | 84,286 | 81,118 | 71,664 | 70,897 | 70,368 | 70,152 |
EBITDA(千元) | -128,171 | -111,609 | -111,859 | -108,865 | -149,293 | -105,294 | -136,824 | -141,579 | -145,599 | -134,103 |